Role of Wnt5b‐Ror1 signaling in the proliferation of pancreatic ductal adenocarcinoma cells
Genes to Cells · 2024
DOI: 10.1111/gtc.13115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, 2024. Verfasst von Natsuko Yamauchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cell Physiology, Department of Physiology and Cell Biology, Graduate School of Medicine, Kobe University, Kobe, Japan. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Cell Proliferation, Pancreatic Neoplasms, Receptor Tyrosine Kinase-like Orphan Receptors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: COI-NEXT Support Unit for Imaging Science at Kento, Center for Medical Transformation (CMX) Young Scientists Collaborative Research Project, Moonshot Research and Development Program.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most refractory cancers with the worst prognosis. Although several molecules are known to be associated with the progression of PDAC, the molecular mechanisms underlying the progression of PDAC remain largely elusive. The Ror‐family receptors, Ror1 and Ror2, which act as a receptor(s) for Wnt‐family ligands, particularly Wnt5a, are involved in the progression of various types of cancers. Here, we show that higher expression of Ror1 and Wnt5b , but not Ror2 , are associated with poorer prognosis of PDAC patients, and that Ror1 and Wnt5b are expressed highly in a type of PDAC cell lines, PANC‐1 cells. Knockdown of either Ror1 or Wnt5b in PANC‐1 cells inhibited their proliferation significantly in vitro, and knockout of Ror1 in PANC‐1 cells resulted in a significant inhibition of tumor growth in vivo. Furthermore, we show that Wnt5b‐Ror1 signaling in PANC‐1 cells promotes their proliferation in a cell‐autonomous manner by modulating our experimental setting in vitro. Collectively, these findings indicate that Wnt5b‐Ror1 signaling might play an important role in the progression of some if not all of PDAC by promoting proliferation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cell Physiology, Department of Physiology and Cell Biology, Graduate School of Medicine, Kobe University, Kobe, Japan.
- Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe, Japan.
- Center for Infectious Disease Education and Research, Osaka University, Suita, Japan.
- Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
ORCID-Profile: Yasuhiro Minami
Förderung
- COI-NEXT Support Unit for Imaging Science at Kento
- Center for Medical Transformation (CMX) Young Scientists Collaborative Research Project
- Moonshot Research and Development Program
Zitieren
APA
Yamauchi, N., Otsuka, M., Ishikawa, T., Kakeji, Y., Kikuchi, A., Masuda, A., Kodama, Y., Minami, Y., & Kamizaki, K. (2024). Role of Wnt5b‐Ror1 signaling in the proliferation of pancreatic ductal adenocarcinoma cells. Genes to Cells. https://doi.org/10.1111/gtc.13115
Vancouver
Yamauchi N, Otsuka M, Ishikawa T, Kakeji Y, Kikuchi A, Masuda A, et al. Role of Wnt5b‐Ror1 signaling in the proliferation of pancreatic ductal adenocarcinoma cells. Genes to Cells. 2024. doi:10.1111/gtc.13115
BibTeX
@article{Yamauchi2024,
author = {Yamauchi, Natsuko and Otsuka, Mako and Ishikawa, Tomohiro and Kakeji, Yoshihiro and Kikuchi, Akira and Masuda, Atsuhiro and Kodama, Yuzo and Minami, Yasuhiro and Kamizaki, Koki},
title = {Role of Wnt5b‐Ror1 signaling in the proliferation of pancreatic ductal adenocarcinoma cells},
journal = {Genes to Cells},
year = {2024},
doi = {10.1111/gtc.13115}
}
EUVIMED